AR046956A1 - Formas cristalinas de la sal mesilato de 2,3- dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazo(1,2-a)piridin-6-carboxamida - Google Patents

Formas cristalinas de la sal mesilato de 2,3- dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazo(1,2-a)piridin-6-carboxamida

Info

Publication number
AR046956A1
AR046956A1 ARP040104749A ARP040104749A AR046956A1 AR 046956 A1 AR046956 A1 AR 046956A1 AR P040104749 A ARP040104749 A AR P040104749A AR P040104749 A ARP040104749 A AR P040104749A AR 046956 A1 AR046956 A1 AR 046956A1
Authority
AR
Argentina
Prior art keywords
imidazo
dimethyl
carboxamide
dimethylbencilamine
hydroxyetyl
Prior art date
Application number
ARP040104749A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30768770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR046956(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR046956A1 publication Critical patent/AR046956A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere a formas cristalinas de la sal mesilato de 2,3-dimetil-8-(2,6-dimetilbencilamino)-N-hidroxietil-imidazo[1,2-a]piridin-6-carboxamida, además se refiere a procesos para obtenerlas, al uso de dichos compuestos para el tratamiento de trastornos gastrointestinales y composiciones farmacéuticas que los contienen.
ARP040104749A 2003-12-18 2004-12-17 Formas cristalinas de la sal mesilato de 2,3- dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazo(1,2-a)piridin-6-carboxamida AR046956A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303451A SE0303451D0 (sv) 2003-12-18 2003-12-18 New compounds

Publications (1)

Publication Number Publication Date
AR046956A1 true AR046956A1 (es) 2006-01-04

Family

ID=30768770

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040104749A AR046956A1 (es) 2003-12-18 2004-12-17 Formas cristalinas de la sal mesilato de 2,3- dimetil-8-(2,6-dimetilbencilamino)-n-hidroxietil-imidazo(1,2-a)piridin-6-carboxamida

Country Status (25)

Country Link
US (1) US7459463B2 (es)
EP (1) EP1697360B1 (es)
JP (2) JP2007514744A (es)
KR (1) KR20060125803A (es)
CN (1) CN1894246B (es)
AR (1) AR046956A1 (es)
AT (1) ATE499371T1 (es)
AU (1) AU2004299435B2 (es)
BR (1) BRPI0417640A (es)
CA (1) CA2549144A1 (es)
CO (1) CO5721004A2 (es)
DE (1) DE602004031556D1 (es)
ES (1) ES2359829T3 (es)
HK (1) HK1095810A1 (es)
IL (1) IL175957A0 (es)
MX (1) MXPA06006708A (es)
MY (1) MY140450A (es)
NO (1) NO20063309L (es)
RU (1) RU2376306C2 (es)
SE (1) SE0303451D0 (es)
TW (1) TW200526659A (es)
UA (1) UA84443C2 (es)
UY (1) UY28676A1 (es)
WO (1) WO2005058895A1 (es)
ZA (1) ZA200604633B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060099524A (ko) * 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4040632A1 (de) * 1990-12-19 1992-06-25 Kali Chemie Pharma Gmbh Phenylalkylaminoalkyl-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
SE512531C2 (sv) 1997-09-04 2000-03-27 Astacarotene Ab Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
SE9801526D0 (sv) 1998-04-29 1998-04-29 Astra Ab New compounds
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
SE0100295D0 (sv) 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
MXPA03007092A (es) * 2001-02-13 2003-11-18 Astrazeneca Ab Nueva formulacion de liberacion modificada.
EP1506016A2 (en) * 2002-05-07 2005-02-16 ALTANA Pharma AG New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders

Also Published As

Publication number Publication date
CO5721004A2 (es) 2007-01-31
UY28676A1 (es) 2005-07-29
BRPI0417640A (pt) 2007-03-27
AU2004299435A1 (en) 2005-06-30
RU2006123362A (ru) 2008-01-27
EP1697360B1 (en) 2011-02-23
MY140450A (en) 2009-12-31
EP1697360A1 (en) 2006-09-06
US7459463B2 (en) 2008-12-02
HK1095810A1 (es) 2007-05-18
CA2549144A1 (en) 2005-06-30
IL175957A0 (en) 2006-10-05
CN1894246A (zh) 2007-01-10
WO2005058895A1 (en) 2005-06-30
ZA200604633B (en) 2007-04-25
ATE499371T1 (de) 2011-03-15
US20070112021A1 (en) 2007-05-17
JP2012102143A (ja) 2012-05-31
CN1894246B (zh) 2011-06-22
MXPA06006708A (es) 2006-08-18
ES2359829T3 (es) 2011-05-27
JP2007514744A (ja) 2007-06-07
TW200526659A (en) 2005-08-16
DE602004031556D1 (de) 2011-04-07
RU2376306C2 (ru) 2009-12-20
AU2004299435B2 (en) 2008-04-17
NO20063309L (no) 2006-09-14
UA84443C2 (ru) 2008-10-27
SE0303451D0 (sv) 2003-12-18
KR20060125803A (ko) 2006-12-06

Similar Documents

Publication Publication Date Title
UY29838A1 (es) Derivados sustituidos de 4,5,6,7-tetrahidropirrolo(3,2,c)piridin-4-ona y de 4,5-tetrahidropirrolo(3,2,c)piridin-4-ona, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
AR049126A1 (es) Derivados de 5, 6, 7, 8 - tetrahidroimidazo[1,5a]piridina con actividad inhibitoria de la aldosterona sintasa, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del hiperaldosterismo y del sindrome de cushing.
AR048912A1 (es) Inmunoglobulinas anti-nogo
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
UY28752A1 (es) Agentes terapeuticos
UY29459A1 (es) Forma cristalina ortorrómbica del maleato de asenapina y su uso en el tratamiento de trastornos mentales
UY27740A1 (es) Nuevos compuestos
ECSP066391A (es) [1,8] naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia
AR054122A1 (es) Pirido[2,3-d]pirimidas utiles como inhibidores de hcv, y metodos para la preparacion de las mismas
UY28374A1 (es) Agentes terapéuticos
UY29781A1 (es) Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
UY28376A1 (es) Agentes terapéuticos
CL2009000161A1 (es) Compuestos derivados de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol; composicion farmaceutica que los comprende; uso en el tratamiento de trastornos neurodegenerativos, cognitivos o psicoticos, enfermedad de alzheimer, entre otros; y un kit que contiene a los compuestos.
AR047966A1 (es) Compuestos poliheterociclicos y su uso como antagonistas del receptor de glutamato metabotropico
UY28510A1 (es) Compuestos quimicos
UY28144A1 (es) Agentes terapéuticos
UY28369A1 (es) Agentes terapéuticos
AR057239A1 (es) Inmunoglobulinas
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
AR055099A1 (es) Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
UY28839A1 (es) Agentes terapeuticos
ECSP12007431A (es) Compuestos orgánicos
ECSP088250A (es) Derivados de pirazol como agentes terapéuticos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal